9.23.2024 - There's No Padding These Results
Sep 23, 2024•9 min•Ep. 233
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Check out this week's Quadcast as we highlight the first randomized trial of SBRT vs. Surgery for prostate cancer, the impact of pembrolizumab on survival in triple negative breast cancer, and the improved survival in limited stage small cell lung cancer with the addition of Durvalumab.
Check out the website and subscribe to the newsletter!
Founders & Lead Authors: Laura Dover & Caleb Dulaney
Podcast Host: Sam Marcrom
For the best experience, listen in Metacast app for iOS or Android